LBF20207PG25: Difference between revisions

No edit summary
No edit summary
Line 19: Line 19:
|Symbol=PGF2<FONT FACE="Symbol">a</FONT>
|Symbol=PGF2<FONT FACE="Symbol">a</FONT>
|Biological Activity=Prostaglandin F2<FONT FACE="Symbol">a</FONT> exhibits various biological activities such as uterine contraction, gastrointestinal contraction, bronchoconstriction, luteolysis and vasoconstriction [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]]. Prostaglandin F2<FONT FACE="Symbol">a</FONT> is a ligand to a receptor (FP) present in the cell membrane [[Reference:Negishi_M:Sugimoto_Y:Ichikawa_A:,Biochim. Biophys. Acta,1995,1259,109|{{RelationTable/GetFirstAuthor|Reference:Negishi_M:Sugimoto_Y:Ichikawa_A:,Biochim. Biophys. Acta,1995,1259,109}}]].
|Biological Activity=Prostaglandin F2<FONT FACE="Symbol">a</FONT> exhibits various biological activities such as uterine contraction, gastrointestinal contraction, bronchoconstriction, luteolysis and vasoconstriction [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]]. Prostaglandin F2<FONT FACE="Symbol">a</FONT> is a ligand to a receptor (FP) present in the cell membrane [[Reference:Negishi_M:Sugimoto_Y:Ichikawa_A:,Biochim. Biophys. Acta,1995,1259,109|{{RelationTable/GetFirstAuthor|Reference:Negishi_M:Sugimoto_Y:Ichikawa_A:,Biochim. Biophys. Acta,1995,1259,109}}]].
|Genetic Information=cDNA for prostaglandin F synthase was cloned from bovine lung [[Reference:Urade_Y:Watanabe_K:Hayaishi_O:,J. Lipid Mediat. Cell Signal.,1995,12,257|{{RelationTable/GetFirstAuthor|Reference:Urade_Y:Watanabe_K:Hayaishi_O:,J. Lipid Mediat. Cell Signal.,1995,12,257}}]]. cDNA for prostaglandin F2<FONT FACE="Symbol">a</FONT> receptor (FP) was cloned, and its 7ptransmembrane structure was reported [[Reference:Negishi_M:Sugimoto_Y:Ichikawa_A:,Biochim. Biophys. Acta,1995,1259,109|{{RelationTable/GetFirstAuthor|Reference:Negishi_M:Sugimoto_Y:Ichikawa_A:,Biochim. Biophys. Acta,1995,1259,109}}]].
}}
}}


{{Lipid/Footer}}
{{Lipid/Footer}}

Revision as of 17:00, 27 January 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



PROSTAGLANDIN F_2α
LBF20207PG25.png
Structural Information
7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenylcyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid
  • PROSTAGLANDIN F_2α
  • 7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenylcyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid
PGF2a
Formula C20H34O5
Exact Mass 354.240624198
Average Mass 354.48096000000004
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC
Physicochemical Information
25-35°C Bundy_GL et al.
[a]XD25=23.8 °(C=1,THF) Corey_EJ et al.
ETHYL ACETATE, ACETONE, DIETHYLETHER Pike_JEet al.. STABILITIES: to be stable under neutral and basic conditions Karim_SM et al.
Prostaglandin F2a was found to be accummulating in human semen in an amount of about 2 microgram per ml Bergstrom_S . In most animal tissues prostanoids are synthesized enzymatically de novo upon physiological and pathological stimulations, and this is also the case of prostaglandin F2a.
Corey_EJ et al.
LBF20207PG25FT0001.gif
Prostaglandin F synthase reduces 9,11-endoperoxide of prostaglandin H2 requiring NADPH, and produces prostaglandin F2a. The same enzyme also reduces 9-keto group of prostaglandin D2 producing 11b-prostaglandin F2 Urade_Y et al..
Prostaglandin F2a exhibits various biological activities such as uterine contraction, gastrointestinal contraction, bronchoconstriction, luteolysis and vasoconstriction Bergstrom_S et al.. Prostaglandin F2a is a ligand to a receptor (FP) present in the cell membrane Negishi_M et al..
cDNA for prostaglandin F synthase was cloned from bovine lung Urade_Y et al.. cDNA for prostaglandin F2a receptor (FP) was cloned, and its 7ptransmembrane structure was reported Negishi_M et al..
Spectral Information
Mass Spectra 354(M+), 336, 318, 292, 274, 264(100), 247, 229, 191, 177, 165, 137, 99, 81, 67 HorvathG
UV Spectra
IR Spectra NEAT : 3320, 2640, 1710, 1295, 1260, 1245, 1120, 1080, 1055, 1025, 975cm-1 Pike_JEet al.
NMR Spectra 1H-NMR(d6-ACETONE) : d 5.48(m, 4H), 4.05(m, 3H), 0.9(t, 3H, 20-CH3) Pike_JEet al.. 13C-NMR : 176.6(C1), 135.0(C14), 132.8(C5), 129.1(C13 or C6), 128.9(C6 or C13), 77.2(C11), 72.9(C15), 71.8(C9), 55.0(C12), 49.9(C8), 42,6(C10), 36.8(C16), 33.2(C2), 31,5(C18), 26.3(C4), 25.1(C7), 25.1(C17), 24.5 LukacsGet al.
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG25 See above. Bergstrom_S 1967
n.a. LBF20207PG25 See above. Bergstrom_S et al. 1968
n.a. LBF20207PG25 See above. Bundy_GL et al. 1972
n.a. LBF20207PG25 See above. Corey_EJ et al. 1970
n.a. LBF20207PG25 See above. Horvath_G 1976
n.a. LBF20207PG25 See above. Karim_SM et al. 1968
n.a. LBF20207PG25 See above. Lukacs_G et al. 1973
n.a. LBF20207PG25 See above. Negishi_M et al. 1995
n.a. LBF20207PG25 See above. Pike_JE et al. 1969
n.a. LBF20207PG25 See above. Urade_Y et al. 1995